Portrait of Mohammed Attallah, founder of BiomeLogic
Mohammed Attallah
About

From Marine Engineering to Systems Biology

A structural FMEA approach to complex chronic pathophysiology.

Systems biologyMechanistic analysisEN · AR

I am Mohammed Attallah, an independent systems biology consultant, mechanistic analyst, and developer of the Host Capacity Model.

My work bridges thermodynamic fluid dynamics, immunometabolism, organelle biophysics, and host-microbe ecology. I founded BiomeLogic to address a critical flaw in modern healthcare: the failure of reductionist frameworks when applied to complex, multi-system chronic conditions — including recurrent SIBO, Mast Cell Activation Syndrome (MCAS), post-viral syndromes such as Long COVID, hypermobile Ehlers-Danlos Syndrome (hEDS), and refractory dysmotility.

The unconventional foundation: Alexandria to systems architecture

My perspective on human physiology differs from conventionally trained health practitioners because my foundational discipline is not medical dogma — it is structural systems engineering.

Born and raised in Egypt, I earned my degree from the Merchant Marine Academy in Alexandria, specializing in Marine Engineering and Naval Architecture. For years, I trained to analyze, model, and troubleshoot massive closed and semi-closed thermodynamic systems under severe environmental stress. My expertise centered on fluid dynamics, energy conversion kinetics, boundary-layer mechanics, stress corrosion cracking, and Systemic Failure-Mode and Effects Analysis (FMEA).

When I moved to the United States twelve years ago, my analytical focus shifted from mechanical and naval structures to the most intricate dynamic architecture in existence: the human organism.

What I discovered was striking. The human gastrointestinal, vascular, and neuro-immune networks obey the same physical and thermodynamic laws that govern complex engineering systems:

Marine engineering & naval architectureHuman systems biology & pathophysiology
Hull stress corrosion crackingExtracellular matrix degradation — enzymatic breakdown of collagen scaffolding and tight-junction networks in hypermobile (hEDS) and MCAS patients.
Cavitation & boundary-layer failureEnteric motor collapse & lymphatic stasis — hydrodynamic pump failure mirrors submucosal edema, interstitial stagnation, and Migrating Motor Complex (MMC) paralysis.
Engine block bioenergetic failureColonocyte respirasome disassembly — mitochondrial electron-transport-chain uncoupling, NAD⁺ exhaustion, and colonocyte bioenergetic collapse.
Thermodynamic energy conversionMitochondrial OXPHOS & colonocyte β-oxidation.
Boundary-layer & hydrodynamicsMucosal layer rheology & lymphatic clearance.
Material degradation & structural fatigueExtracellular matrix breakdown & tight-junction cleavage.
Closed-loop fluid flow / cavitationMicrovascular ischemia & enteric motor impairment.
Systemic Failure-Mode & Effects AnalysisUpstream mechanistic case reconstruction.

Where traditional medicine sees isolated, disparate symptoms across different organs, an engineer sees a single, interconnected system experiencing structural and thermodynamic failure.

The Host Capacity Model: flipping the microbiome paradigm

This engineering background led directly to the development of the Host Capacity Model.

The conventional gastroenterology paradigm often operates on a simplistic "kill" protocol: identify an overgrowth such as SIBO or dysbiosis and target it with antimicrobials. In recurrent cases, this approach fails because it treats microbial shifts as the cause of pathology, rather than an ecological adaptation to an upstream host substrate failure.

The Host Capacity Model asks an engineering question: What structural or bioenergetic parameters of the microenvironment failed, forcing the ecosystem to adapt?

When host colonocytes lose their bioenergetic capacity to perform β-oxidation — driven by NAD⁺ depletion, SIRT3 deactivation, and mitochondrial oxidative stress — the consequences are strictly physical:

  • Oxygen gradient collapse. The mucosal lining loses its physiological hypoxia (pO₂ < 10 mmHg, or < 1%), allowing atmospheric oxygen to leak into the lumen.
  • Ecological succession. Facultative anaerobes such as Enterobacteriaceae expand by utilizing host-derived electron sinks (nitrate and oxygen), permanently displacing obligate anaerobic butyrate producers.
  • Macromolecular rheology collapse. Pathobiont enzymes cleave terminal sugars from MUC2 mucin glycans, causing a steric and electrostatic surface-charge collapse that degrades the protective mucin hydrogel matrix into an un-entangled polymer solution.

The microbes are not "invading"; they are occupying an ecological niche that the host no longer has the thermodynamic capacity to defend.

Sub-cellular failure-modes: mapping the systemic locks

When host capacity drops below a critical threshold, the body becomes trapped in biochemical feedback loops that prevent self-repair. The Host Capacity Model maps the precise molecular locks that sustain this pathological equilibrium:

  • Glial Connexin-43 hemichannel purinergic leaking. Reactive enteric glial cells open large-pore Cx43 hemichannels, purging eATP and glutamate into the extraneuronal space, causing excitotoxic loss of nitrergic motor neurons and permanent MMC paralysis.
  • The ACOD1 / itaconate trap. Translocated bacterial antigens activate macrophage ACOD1/IRG1, producing itaconate that competitively inhibits Succinate Dehydrogenase (Complex II), locking neighboring enterocytes in paracrine energy starvation.
  • The iNOS nitrate electron sink. Inflammatory cytokine surges upregulate inducible Nitric Oxide Synthase (iNOS), producing nitrate (NO₃⁻) at the brush border — providing pathobionts with the exact terminal electron acceptor needed to maintain dominance.
  • PDH S-nitrosylation lock. Excess nitric oxide directly S-nitrosylates Pyruvate Dehydrogenase (PDH), blocking Acetyl-CoA synthesis and freezing the TCA cycle regardless of caloric intake.
  • PAR-2 & MMP-9 matrix degradation. Mast cell tryptase cleaves Protease-Activated Receptor-2 (PAR-2), activating matrix metalloproteinases (MMP-9) that dissolve the structural collagen matrix supporting the enteric nervous system.

Independent mechanistic analysis: the role of BiomeLogic

BiomeLogic operates outside the traditional clinical delivery model. I do not operate as a clinician; I operate as an independent systems analyst and pattern-recognition specialist.

Modern medicine is heavily siloed. A patient presenting with post-viral dysautonomia, mast cell instability, and chronic intestinal pseudo-obstruction is routinely split between a gastroenterologist, an immunologist, and a neurologist. Each specialist applies localized, symptomatic treatments within a 15-minute insurance slot, missing the unified thermodynamic collapse occurring underneath.

My role is to reconstruct the master causal chain:

  • Complete systemic reconstruction. I evaluate a client’s history, symptom chronology, lab testing, genetic proxies, and failed interventions as a single, integrated engineering schematic.
  • Failure-mode mapping. I isolate the exact bioenergetic, structural, or neuro-immune locks that prevent host recovery.
  • Clinician-ready deliverables. I generate granular, peer-review-grade mechanistic reports that make the explicit reasoning shareable with the client’s licensed medical team.

Unwavering commitment to scientific rigor

BiomeLogic is built on absolute scientific candor and physical reality. I do not deal in vague, non-mechanistic wellness concepts. Every assertion within the Host Capacity Model is anchored in biochemistry, cellular energetics, electrophysiology, and macromolecular physics.

By treating the human body with the structural precision of a complex engineered system, BiomeLogic provides a path forward for those whose cases have been deemed puzzling, untreatable, or refractory. I help you understand not just why your system collapsed, but the exact physical parameters required to rebuild its capacity.

Mohammed Attallah

Founder & Mechanistic Analyst, BiomeLogic

Bowie, Maryland, USA

BiomeLogic is not clinical care. Mohammed is not a licensed clinician and does not diagnose, treat, or prescribe. See the scope of practice.

  • Educational systems-biology consulting · Not diagnosis
  • Not diagnosis or treatment
  • Works alongside your licensed care team
  • Written mechanistic summary
  • Fictional sample report available
  • No files required for Gate 1
Skeptical FAQ

Hard Questions

For full provenance, see the Framework Audit, Counterargument Library, and Claim Ledger.